Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press features

  4. Media kit on COVID-19

Media kit on COVID-19

Last update: May, 4, 2021

“66,000 Siemens Healthineers colleagues are sparing no effort and working wherever and however they can to provide clinical experts with the help and technical solutions they need in their fight against COVID-19.”

Bernd Montag, CEO Siemens Healthineers

Published on March 24, 2020

Image Gallery

High quality and targeting the right protein are all essential to ensure we effectively manage the threat of COVID-19. See here all information on the total antibody test at a glance.

Total Antibody Test At a Glance

High quality and targeting the right protein are all essential to ensure we effectively manage the threat of COVID-19. See here all information on the total antibody test at a glance.

Download Image

Test detects antibodies to spike protein – a key protein

Importantly, the test detects antibodies to a key protein on the surface of the SARS-CoV-2 virus—a spike protein, which binds the virus to cells with a distinct human receptor found in lungs, heart, multiple organs and blood vessels. Studies indicate that certain (neutralizing) antibodies to the spike protein can disarm SARS-CoV-2. Multiple potential vaccines in development for SARS-CoV-2 include the spike protein within their focus.

Siemens Healthineers ramps up production capacity

Siemens Healthineers plans to ship more than 50 million antibody tests per month worldwide as production capacity increases. Find here footage from our sites in Tarrytown (NY) and Walpole (MA) to use for your broadcast. If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.

This test has not been FDA cleared or approved.

Siemens Healthineers ramps up production capacity

Siemens Healthineers plans to ship more than 2.5 million molecular PCR tests per month worldwide as production capacity increases. Find here footage from our site in Marburg, Germany, to use for your broadcast. If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.

Footage of laboratory diagnostics

Siemens Healthineers makes a contribution to fight the current COVID-19 global pandemic significantly through expanding its infectious disease testing capabilities. If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.

Blood gas systems

Blood gas systems support the monitoring of ventilated patients. This footage shows how the systems are used in critical care. To be seen: epoc Blood Analysis System (00:01-00:03), RAPIDPoint 500e Blood Gas System (00:22-00:32). The footage shows the blood analyzer epoc and RAPIDpoint 500e (start image: epoc). If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.

The molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit
cs-virtual_technical_training